| Title | Research Area | Implementing Organisations | Funding Organisations | Start Year | Status |
|---|---|---|---|---|---|
| Design, synthesis and evaluation of novel Thiochromene analogs as potential anti-leishmanial agents | Pharmaceutical Sciences | Birla Institute of Technology and Science | Anusandhan National Research Foundation (ANRF) | 2023 | Ongoing |
| Development and Preclinical evaluation of ATRA-RAMBA retinamides in retinoid-based therapy for Colorectal cancer- Investigational study | Pharmaceutical Sciences | Bharathiar University | Anusandhan National Research Foundation (ANRF) | 2023 | Ongoing |
| Design and Synthesis of Novel Carboline-Nucleosides with Potential Viral RdRp Inhibitor Activity: Development of Broad-Spectrum Antivirals Against RNA Viruses | Pharmaceutical Sciences | National Institute of Pharmaceutical Education and Research (NIPER) Kolkata, West Bengal | Science and Engineering Research Board (SERB), New Delhi | 2023 | Ongoing |
| Design and Evaluation of Novel Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) Inhibitors for the Treatment of Neurodegenerative, Oncogenic and Inflammatory Diseases | Pharmaceutical Sciences | Mit- World Peace University, Pune, Maharashtra | Anusandhan National Research Foundation (ANRF) | 2023 | Ongoing |
| Controlled Drug Delivery in Oral Osmotic Tablets: Experiments and Modelling | Pharmaceutical Sciences | Indian Institute Of Technology (IIT) Bombay, Maharashtra | Science and Engineering Research Board (SERB), New Delhi | 2023 | Ongoing |
| Comparative Study of Topological Descriptors Among Some Well-known Antiviral Drugs Used for the Treatment of Covid-19 Patients | Pharmaceutical Sciences | Banaras Hindu University | Science and Engineering Research Board (SERB), New Delhi | 2023 | Ongoing |
| Cancer environment stimuli-responsive DNA nanoparticles: A unique drug delivery vehicle for combination cancer therapy | Pharmaceutical Sciences | Indian Institute of Science | Science and Engineering Research Board (SERB), New Delhi | 2023 | Ongoing |
| Bioisosteric Approach for the Synthesis of Fumitremorgin C, Tariquidar and Elacridar Analogues for Reversing Multidrug Resistance in Cancer | Pharmaceutical Sciences | Mohan Lal Sukhadia University, Rajasthan | Science and Engineering Research Board (SERB), New Delhi | 2023 | Ongoing |
| Development and validation of improved AI/MLbased selectivity models for HDACs, a epigenetic target for cancer, neurodegenerative diseases | Pharmaceutical Sciences | Jadavpur University | Science and Engineering Research Board (SERB), New Delhi | 2023 | Ongoing |
| Targeting myeloid leukemia stem cells derived from induced pluripotent stem cells (iPSCs) using high-throughput screening of FDA-approved drugs to overcome drug resistance | Pharmaceutical Sciences | Christian Medical College | Anusandhan National Research Foundation (ANRF) | 2023 | Ongoing |
Accessibility Controls